1

Deirdre Fulton – Big Pharma Preps to Spend Hundreds of Millions to Keep Drug Prices High

Facing an increasingly outraged public, the leading Big Pharma lobby group is hiking its annual dues by more than 50 percent as it prepares to defend its pharmaceutical company members against lawmakers and voters who want to rein in out-of-control drug prices. Politico reported Tuesday that “PhRMA hopes to improve its public image next year and stave off any legislative …

1

Martin Shkreli Is Just One of Many Pharma A-Holes

They throw lavish boat parties while marking up life-saving medication 5,000 percent. Nancy Retzlaff is not Martin Shkreli. She won’t inspire hundreds of news articles nor will she become the subject of any Internet memes. She won’t threaten Ghostface Killah and it seems unlikely that she will ever flirt with a minor on a YouTube livestream. But the chief commercial officer for Turing Pharma …

1

4 of the Most Commonly Prescribed Drugs That May Be a Lot More Risky Than Pharma Is Letting On

They are so common no one thinks twice about them: drug ads that tell you about a disease you might have, a pill that could treat it, and tell you to “ask your doctor” if the pill is right for you. Until 1997, such direct-to-consumer ads did not exist because without a doctor’s recommendation, how could people know if the …

1

Pharma CEO: We’re in Business of Shareholder Profit, Not Helping the Sick

Another Pharmaceutical CEO is stepping up to challenge Martin Shkreli as world’s most hated man. Last month, Martin Shkreli became a household name. The CEO of Turing Pharmaceuticals is now infamous for raising the price of a newly-acquired drug to $750 a pill. He also explained in an interview that his company was not alone in acquiring drugs currently on …

1

Infectious Myth – Edmond McNack and his Awful AIDS Drug Experience – 09.29.15

March 25, 1998 changed Edmond McNack’s life. It wasn’t that there was anything special that this sheriff’s deputy was transporting. It wasn’t that when she bit him she actually harmed him. But the fear of HIV transmission was so great that he was immediately put on a 12 week course of PEP (Post-Exposure Prophylaxis). And these toxic AIDS drugs destroyed his health in the ten weeks that he persisted and changed the course of his life.
David talks with Edmond in this Episode 72, about how quickly the AIDS drugs caused serious health problems, problems that continue today. Another astonishing aspect of this case is that, in a bizarre ruling, the Missouri Labor and Industrial Relations Commission denied him compensation, because a doctor stated that although the drugs he’d been given could easily cause his symptoms in an HIV-positive person, there was no information on their effect on HIV-negative people. Even though HIV obviously played no role in the side effects.
Despite this Edmond McNack has always maintained a positive attitude, and is happy to share his story, to give other people, possibly faced with a similar situation, pause to think.
You can email Edmond atedmondmcnack@yahoo.com or phone him at +1-816-325-0587

1

Nick Barrickman – US pharmaceutical industry price-gouging and the case of Martin Shkreli

The decision by biotechnology firm Turing Pharmaceuticals to raise the cost of Pyrimethamine (or Daraprim), a drug used to treat toxoplasmosis, from $13.50 to more than $750 per pill, has aroused shock and outrage. Toxoplasmosis is a parasitic disease to which people with weakened immune systems from of diseases such as AIDS, as well as certain cancer patients, as well …

1

JUDD LEGUM – After Getting Shamed For 5000% Hike, ‘Most Hated Man In America’ Will Lower Drug Price

Martin Shkreli, the controversial pharmaceutical CEO and former hedge fund manager, announced that he would reduce the price of the drug Daraprim to “a point that is more affordable.” Shkreli has been the subject of unrelenting criticism since he implemented a 5000% increase in the price of the drug — from $13.50 per pill to $750 — which is used …

1

MARY ELIZABETH WILLIAMS – “Martin Shkreli is the Donald Trump of drug development”: Why even a biotech exec agrees Turing’s pill price-gouging is “even skeevier than you think”

“Martin Shkreli is the Donald Trump of drug development,” my friend Frank tells me. “He’s a hedge fund manager who gives hedge fund managers a bad name.” Frank — a chief scientific officer at a biotech company (and whose name has been changed to protect his and his family’s privacy) — is talking to me Tuesday morning, en route to …